Federation Des Caisses Desjardins Du Quebec Biogen Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Biogen Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 10,104 shares of BIIB stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,104

Previous 9,106 10.96%

Holding current value

$1.52 Million

Previous $2.11 Million 7.2%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $188,691 - $236,326	998 Added 10.96%	10,104 $1.96 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $542,791 - $674,415	-2,849 Reduced 23.83%	9,106 $2.11 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $2.53 Million - $3.2 Million	11,955 New	11,955 $2.76 Billion
Q4 2023 Aug 14, 2024	SELL	$222.59 - $267.94 $1.32 Million - $1.59 Million	-5,924 Reduced 35.84%	10,605 $2.74 Billion
Q3 2023 Aug 14, 2024	SELL	$253.3 - $285.89 $338,408 - $381,949	-1,336 Reduced 7.48%	16,529 $4.25 Billion
Q2 2023 Aug 14, 2024	BUY	$275.25 - $318.06 $1.68 Million - $1.95 Million	6,121 Added 52.12%	17,865 $5.09 Billion
Q1 2023 Aug 14, 2024	BUY	$256.56 - $292.34 $426,402 - $485,869	1,662 Added 16.48%	11,744 $3.27 Billion
Q4 2022 Aug 14, 2024	SELL	$252.44 - $306.72 $11,612 - $14,109	-46 Reduced 0.45%	10,082 $2.79 Billion
Q3 2022 Aug 14, 2024	SELL	$194.69 - $268.46 $652,406 - $899,609	-3,351 Reduced 24.86%	10,128 $2.7 Billion
Q2 2022 Aug 14, 2024	BUY	$187.54 - $223.02 $46,697 - $55,531	249 Added 1.88%	13,479 $2.75 Billion
Q1 2022 Aug 14, 2024	BUY	$193.77 - $244.14 $799,107 - $1.01 Million	4,124 Added 45.29%	13,230 $2.79 Billion
Q4 2021 Aug 30, 2024	SELL	$223.92 - $287.77 $35,155 - $45,179	-157 Reduced 1.16%	13,361 $3.21 Billion
Q3 2021 Aug 30, 2024	SELL	$282.99 - $369.05 $105,555 - $137,655	-373 Reduced 2.69%	13,518 $3.82 Billion
Q2 2021 Aug 30, 2024	BUY	$259.0 - $414.71 $1.24 Million - $1.98 Million	4,785 Added 52.55%	13,891 $4.81 Billion
Q1 2021 Aug 30, 2024	SELL	$242.95 - $284.63 $748,771 - $877,229	-3,082 Reduced 15.12%	17,295 $4.84 Billion
Q4 2020 Aug 30, 2024	BUY	$236.26 - $355.63 $2.19 Million - $3.29 Million	9,265 Added 83.38%	20,377 $4.99 Billion
Q3 2020 Aug 30, 2024	BUY	$264.77 - $305.71 $84,196 - $97,215	318 Added 2.95%	11,112 $3.15 Billion
Q2 2020 Aug 30, 2024	BUY	$258.66 - $342.55 $75,270 - $99,682	291 Added 2.77%	10,794 $2.89 Billion
Q1 2020 Aug 30, 2024	SELL	$268.85 - $341.04 $1.3 Million - $1.65 Million	-4,838 Reduced 31.54%	10,503 $3.32 Billion
Q4 2019 Aug 30, 2024	BUY	$220.06 - $304.07 $162,624 - $224,707	739 Added 5.06%	15,341 $4.55 Billion
Q3 2019 Aug 30, 2024	BUY	$217.44 - $243.88 $1.72 Million - $1.93 Million	7,907 Added 118.1%	14,602 $3.4 Billion
Q2 2019 Aug 30, 2024	SELL	$219.29 - $241.72 $35,305 - $38,916	-161 Reduced 2.35%	6,695 $1.57 Billion
Q1 2019 Aug 30, 2024	SELL	$216.71 - $338.96 $61,328 - $95,925	-283 Reduced 3.96%	6,856 $1.62 Billion
Q4 2018 Aug 30, 2024	SELL	$278.5 - $352.75 $547,809 - $693,859	-1,967 Reduced 21.6%	7,139 $2.15 Billion
Q3 2018 Aug 30, 2024	BUY	$293.51 - $383.83 $304,663 - $398,415	1,038 Added 11.77%	9,858 $3.48 Billion
Q2 2018 Aug 30, 2024	BUY	$257.52 - $306.91 $54,594 - $65,064	212 Added 2.46%	8,820 $2.56 Billion
Q1 2018 Aug 30, 2024	SELL	$260.13 - $367.91 $141,510 - $200,143	-544 Reduced 5.94%	8,608 $2.36 Billion
Q4 2017 Aug 30, 2024	BUY	$307.64 - $344.58 $130,131 - $145,757	423 Added 4.85%	9,152 $2.92 Billion
Q3 2017 Aug 30, 2024	SELL	$281.15 - $329.69 $128,766 - $150,998	-458 Reduced 4.99%	8,729 $2.73 Billion
Q2 2017 Aug 30, 2024	BUY	N/A	576 Added 6.69%	9,187 $2.49 Billion
Q1 2017 Aug 30, 2024	SELL	N/A	-495	8,611 $2.35 Billion

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Biogen Inc. Transaction History